A. Kaisary

发表

Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)—Agonist Therapy in Prostate Cancer

M. Jarmulowicz, A. Kaisary, 2003 .

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers

J. A. Hamilton, I. Gray, D. Snary, 2000, British Journal of Cancer.

Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?

P. Iversen, T. Morris, A. Kaisary, 2001, Prostate Cancer and Prostatic Diseases.

Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.

A. Nagafuchi, M. Pignatelli, A. Karayiannakis, 1997, Cancer research.

Laparoscopic versus open simple prostatectomy: a comparative study.

A V Kaisary, A. Ballaro, H Baumert, 2006, The Journal of urology.

The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study

I. Melezínek, P. Iversen, G. Blake, 2003, World Journal of Urology.

Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

T. Tammela, P. Iversen, T. Morris, 2006, BJU international.

The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy

E. Kulinskaya, M. Winkler, G. Boustead, 2004, BJU international.

LH-RH Agonist Role in Prostate Cancer Management

A. Kaisary, 2009 .

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Bicalutamide: A Viewpoint by Amir V. Kaisary

A. Kaisary, 2002 .

Contemporary update of cancer control after radical prostatectomy in the UK

D. Gillatt, R. Persad, M. Winkler, 2004, British Journal of Cancer.

IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer

R. Dina, J. Waxman, H. Stauss, 2009, Clinical Cancer Research.

HIGH‐INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: INITIAL EXPERIENCE WITH A 2‐YEAR FOLLOW‐UP

R. Nigam, A. Kaisary, J. Barua, 2009, BJU international.

Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer. Avorelin Study Group.

D. Gillatt, B. Imbimbo, P. Malone, 1999, The Journal of urology.

A randomised comparison of monotherapy with Casodex 50 mg daily and castration in the treatment of metastatic prostate carcinoma. Casodex Study Group.

F. Debruyne, G. Lunglmayr, A. Kaisary, 1995, European urology.

"Beehive on the bladder": an indication of colovesical disease.

A. Kaisary, R. Grant, 1984, British journal of urology.

Assessment of radiotherapy in invasive bladder carcinoma using in vivo methylene blue staining technique.

A. Kaisary, 1986, Urology.

Contractile actions of imidazoline α-adrenoceptor agonists and effects of noncompetitive α1-adrenoceptor antagonists in human vas deferens

J. Guillebaud, A. Kaisary, R. W. Lloyd-Davies, 2003 .

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter study.

M. Marberger, C. Leuratti, N. Shore, 2010, Clinical therapeutics.

PSA recurrence following radical prostatectomy is comparable for all age groups in the UK

D. Gillatt, M. Winkler, G. Boustead, 2005, Prostate Cancer and Prostatic Diseases.

Current clinical studies with a new nonsteroidal antiandrogen, casodex

A. Kaisary, Kaisary Av, 1994, The Prostate. Supplement.

Antiandrogen monotherapy in the management of advanced prostate cancer.

A. Kaisary, 1997, European urology.

Angiomyolipoma of the kidney: a clinical enigma in diagnosis and management.

M. Hershman, A. Kaisary, K. Wong, 1992, Annals of the Royal College of Surgeons of England.

Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.

K. Livak, P. Unger, R. Stock, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

'Beehive on the bladder': a sign of colovesical fistula.

A. Kaisary, R. Grant, 1981, Annals of the Royal College of Surgeons of England.

A study of cefamandole prostatic tissue levels.

A. Kaisary, 1981, British journal of urology.

In vitro deregulation of markers characteristic of human prostate epithelial cells.

J. Waxman, T. Kamalati, Anup Patel, 2004, Tissue & cell.

The incidence and treatment of lymphoceles after radical retropubic prostatectomy

R. Pepper, J. Pati, A. Kaisary, 2005, BJU international.

Greenlight Prostatectomy: A Challenge to the Gold Standard?: A Review of KTP Photoselective Vaporization of the Prostate

H. Ahmed, M. Arya, I. Shergill, 2007, Surgical laparoscopy, endoscopy & percutaneous techniques.

Conservative management of unintentional distal embolization following intravascular occlusive therapy

G. Williams, J. Mcivor, A. Kaisary, 1982, The British journal of surgery.

The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy.

P. Mulders, B. Knipscheer, A. Ballaro, 2006, European urology.

Multiple unilateral renal angiomyolipomas with regional lymphangioleiomyomatosis.

A. Kaisary, N. Chronos, G. McIntosh, 1989, The Journal of urology.

Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer

A. Kaisary, 2005, Prostate Cancer and Prostatic Diseases.

Anti-Androgen (Flutamide) Therapy in Management of Relapsing Metastatic Prostatic Carcinoma

A. Kaisary, G. Fellows, Joseph C. Smith, 1987 .

Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective mu

A. Zlotta, M. Remzi, M. Marberger, 2002, Urology.

Alfuzosinof the Therapeutic Use of the Prolonged-Release Formulation Given Once Daily in the Management of Benign Prostatic Hyperplasia

T. Tammela, C. Chapple, C. Mey, 2002 .

Surgery in Motion The Use of Polymer ( Hemo-lok ) Clips for Management of the Renal Hilum During Laparoscopic Nephrectomy

P. Mulders, B. Knipscheer, A. Ballaro, 2006 .

Postoperative care following internal urethrotomy.

A V Kaisary, A. Kaisary, 1985, Urology.

Tumour infarction after pre-operative embolisation of renal carcinoma.

G. Williams, J. Mcivor, A. Kaisary, 1984, Clinical radiology.

NANOTECHNOLOGY: POTENTIAL APPLICATIONS IN UROLOGY

H. Ahmed, A. Tsiouris, A. Kaisary, 2006, BJU international.

Incarcerated small bowel hernia through drain site.

A. Kaisary, B. Krijgsman, D. Sharma, 2004, Annals of the Royal College of Surgeons of England.

Urachal tumour: clinical and radiological features of a poorly understood carcinoma.

H. Ahmed, A. Tsiouris, A. Kaisary, 2007, Annals of the Royal College of Surgeons of England.

Time trends in case selection, stage and prostate‐specific antigen recurrence after radical prostatectomy: a multicentre audit

D. Gillatt, R. Persad, M. Winkler, 2004, BJU international.

A temporary biological dressing in the treatment of varicose ulcers and skin defects.

A. Kaisary, 1977, Postgraduate medical journal.

Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer

P. Teillac, O. Bouchot, A. Kaisary, 2004, Hormone Research in Paediatrics.

The effect on sexual interest of `Casodex' (bicalutamide). 150 mg compared with castration in patients with advanced prostate cancer

T. Tammela, P. Iversen, H. Poppel, 2000 .

Spinal cord ischemia after ligation of both internal iliac arteries during radical cystoprostatectomy.

P. Smith, A. Kaisary, 1985, Urology.

MRI is too insensitive to stage early prostate cancer

M. Laniado, F. A. Khan, M. E. Laniado, 2003 .

Patient-Clinician Choice in Palliation of Metastatic Prostate Cancer

A. Kaisary, 2000, Drugs & aging.

Phase III efficacy and safety trial of a new leuprolide acetate 3.75 mg depot formulation in prostate cancer patients.

M. Marberger, C. Leuratti, N. Shore, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

European Study of Radical Prostatectomy: time trends in Europe, 1993–2005

A. Zlotta, M. Marberger, V. Ravery, 2007, BJU international.

Treatment of balanitis xerotica obliterans with topical tacrolimus.

M. Rustin, A. Kaisary, B. Pandher, 2003, The Journal of urology.

Case selection for radical prostatectomy in the UK.

D. Gillatt, R. Persad, M. Winkler, 2004, European urology.

What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria.

M. Remzi, T. Anagnostou, B. Djavan, 2005, Reviews in urology.

172 Diameter of the largest focus of peri-neural invasion in the radical prostatectomy specimen as a predictor of eventual treatment failure

M. Jarmulowicz, M. Laniado, A. Kaisary, 2004 .

553 Percentage of positive prostate biopsies cores is an additional predictor of pathological stage and margin status at radical prostatectomy — A UK experience

M. Winkler, G. Boustead, A. Kaisary, 2004 .

129 PSA molecular forms and indices for early detection of prostate cancer in men with total PSA between 2.0 and 4.0 ng/ml: final results of the EPCD study

A. Zlotta, M. Remzi, M. Marberger, 2004 .

Primary localised amyloidosis of the urethra.

A. Kaisary, 1985, European Urology.

482 PROSPECTIVE STUDY OF EXTRACORPOREAL MAGNETIC INNERVATION PELVIC FLOOR THERAPY (EXMI) VERSUS STANDARD PELVIC FLOOR TRAINING FOLLOWING RADICAL PROSTATECTOMY: IMPACT ON TIMING AND MAGNITUDE OF RECOVERY OF CONTINENCE

R. Herwig, M. Marberger, T. Anagnostou, 2007 .

Prazosin, priapism and management.

P. Smith, A. Kaisary, 1986, British journal of urology.

A Randomised Comparison of ‘Casodex’TM (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer

T. Tammela, L. Baert, P. Iversen, 1998, European Urology.

Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.

K. Griffiths, W. Peeling, A. Kaisary, 1991, British journal of urology.

Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.

R. Branch, P. Smith, G. Wilkinson, 1987, Cancer research.

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.

T. Tammela, I. Melezínek, P. Iversen, 2000, The Journal of urology.

Localised carcinoma of the prostate: a paradigm of uncertainty.

A. Kaisary, S. Sandhu, A. Kaisary, 1997, Postgraduate medical journal.

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.

I. Melezínek, P. Iversen, H. Van Poppel, 2000, The Journal of urology.

M. Marberger, C. Leuratti, N. Shore, 2010, Clinical therapeutics.

Use of Collagen Implant for Posterior Rectopexy in Complete Rectal Prolapse: Preliminary Communication

A. Kaisary, J. Pendower, R. J. Luck, 1984, Journal of the Royal Society of Medicine.